Singapore markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
54.23-0.56 (-1.02%)
At close: 04:00PM EST
54.15 -0.08 (-0.15%)
After hours: 07:27PM EST
Full screen
Trade prices are not sourced from all markets
Previous close54.79
Bid0.00 x 1800
Ask0.00 x 1800
Day's range53.64 - 54.65
52-week range46.48 - 64.21
Avg. volume5,349,492
Market cap168.745B
Beta (5Y monthly)0.15
PE ratio (TTM)100.15
Earnings dateN/A
Forward dividend & yield1.40 (2.58%)
Ex-dividend date12 Aug 2021
1y target estN/A
  • Motley Fool

    Here's Why AstraZeneca Stock Could Help Make You Rich

    The pharmaceutical is a high-quality dividend stock that offers investors tremendous growth at a reasonable price.

  • Motley Fool

    Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?

    Moderna (NASDAQ: MRNA) and AstraZeneca (NASDAQ: AZN) compete against each other in some markets with their respective COVID-19 vaccines. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Moderna's and AstraZeneca's mRNA candidate could be a winner.

  • Reuters SG

    UPDATE 3-Shares in drugmaker Sobi tumble as Advent, Aurora withdraw $8 bln bid

    Shares in Sweden's Orphan Biovitrum (Sobi) plunged 23% on Friday after U.S. private equity firm Advent International and Singapore's sovereign wealth fund said they were withdrawing their bid for the drugmaker. The company in September agreed to an $8 billion takeover by Advent and Aurora, an investment vehicle of Singapore's GIC Pte Ltd, through Agnafit Bidco. "Since the acceptance level condition has not been fulfilled, Agnafit Bidco hereby withdraws the offer," Agnafit Bidco said in a statement.